Interlaboratory-concordance of PD-L1 IHC for NSCLC

被引：0
|
作者：
Scheel, Andreas H.
Banfer, Gudrun
Baretton, Gustavo Bruno
Dietel, Manfred
Diezko, Rolf
Henkel, Thomas
Heukamp, Lukas C.
Jasani, Bharat
Johrens, Korinna
Kirchner, Thomas
Petersen, Iver
Reu, Simone
Schildhaus, Hans-Ulrich
Schirmacher, Peter
Tiemann, Markus
Warth, Arne
Weichert, Wilko
Wolf, Juergen
Ruschoff, Josef
Buettner, Reinhard
机构：
[1] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[2] Targos Mol Pathol GmbH, Kassel, Germany
[3] Univ Hosp Carl Gustav Carus, Dresden, Germany
[4] Charite, Inst Pathol, Berlin, Germany
[5] TARGOS Mol Pathol GmbH, Kassel, Germany
[6] Haematopathol Hamburg, Hamburg, Germany
[7] NEO New Oncol GmbH, Hamburg, Germany
[8] Charite, Inst Pathol, Campus Berlin Mitte, Berlin, Germany
[9] Univ Munich, Dept Pathol, Munich, Germany
[10] Univ Hosp Jena, Inst Pathol, Jena, Germany
[11] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany
[12] Univ Hosp Gottingen, Inst Pathol, Gottingen, Germany
[13] Heidelberg Univ, Patholog Inst, Heidelberg, Germany
[14] Universitatsklinikum Heidelberg, Dept Pathol, Translat Lung Res Ctr Heidelberg, Heidelberg, Germany
[15] Tech Univ Munich, Inst Pathol, Munich, Germany
[16] Univ Hosp Cologne, Lung Canc Grp Cologne, Ctr Integrated Oncol, Cologne, Germany
[17] Nordhessen & Targos Mol Pathol GmbH, Inst Pathol, Kassel, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20508
引用
收藏
页数：6
相关论文
共 50 条
  • [11] PD-L1 expression in NSCLC
    Janzic, U.
    Kern, I.
    Janzic, A.
    Cavka, L.
    Cufer, T.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S58 - S59
  • [12] Concordance of PD-L1 expression detection in non-small cell lung cancer (NSCLC) tissue biopsies between OncoTect iO single cell PD-L1 quantification assay and immunohistochemistry (IHC).
    Chargin, Amanda
    Morgan, Rian Janine
    Patterson, Bruce Kendrick
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [13] Comparison of PD-L1 mRNA expression measured with the CheckPointTyper® assay with PD-L1 protein expression assessed with immunohistochemistry (IHC) in lung cancer (NSCLC)
    Erber, R.
    Stoehr, R.
    Herlein, S.
    Fuchs, F.
    Veltrup, E.
    Wirtz, R.
    Hartmann, A.
    VIRCHOWS ARCHIV, 2017, 471 : S102 - S102
  • [14] Harmonization of PD-L1 IHC Including LDT
    Bubendorf, L.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S97 - S97
  • [15] PD-L1 antigen stability using PD-L1 IHC pharmDx on human cancer tissues
    Kalpakoff, Megan
    Olander, Emily
    Jones, Kelci
    Hund, Stephanie
    Evans, Tiffany
    Barreto, Joseph
    Moquin, Deanna
    Toland, Grant
    Tabuena-Frolli, Siena
    Kersch, Kristopher
    Kulangara, Karina
    Musser, Jeanette
    CANCER RESEARCH, 2024, 84 (06)
  • [16] Concordance of mRNA expression (nCounter) and protein expression (IHC) for the detection of PD-L1 in patients with advanced non-small cell lung cancer (NSCLC)
    Teixido, Cristina
    Marin, Elba
    Aguado, Cristina
    Pare, Laia
    Gimenez-Capitan, Ana
    Lopez-Prades, Sandra
    Felipe Cardona, Andres
    Cabrera, Carlos
    Gonzalvo, Elena
    Lopez, Laura
    Roman, Ruth
    Martinez, Daniel
    Sullivan, Ivana
    Jares, Pedro
    Prat, Aleix
    Angel Molina-Vila, Miguel
    Reguart, Noemi
    CANCER RESEARCH, 2019, 79 (13)
  • [17] Beyond PD-L1 IHC (TMB, Immune Microenvironment)
    Mino-Kenudsen, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S97 - S98
  • [18] The SP142 PD-L1 IHC assay for atezolizumab (atezo) reflects pre-existing immune status in NSCLC and correlates with PD-L1 mRNA
    Williams, J.
    Kowanetz, M.
    Koeppen, H.
    Boyd, Z.
    Kadel, E. E., III
    Smith, D.
    McCleland, M.
    Zou, W.
    Hegde, P. S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [19] Comprehensive genomic and immune profiling defines immunotherapy treatment in patients with NSCLC with low PD-L1 IHC
    Pabla, Sarabjot
    Seager, Robert J.
    Nesline, Mary
    DePietro, Paul
    Van Roey, Erik
    Gao, Shuang
    Ramkissoon, Shakti
    Deng, Lei
    Zhang, Shengle
    Klein, Roger David
    Conroy, Jeffrey M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [20] Final results of the concordance analysis of PD-L1 immunohistochemistry (IHC) assays and polymerase chain reaction (PCR) in non-small lung cancer (NSCLC) patients
    Tsimafeyeu, I.
    Imyanitov, E. N.
    Zavalishina, L.
    Raskin, G.
    Povilaitite, P.
    Savelov, N.
    Kharitonova, E.
    Rumyantsev, A.
    Pugach, I.
    Andreeva, Y.
    Petrov, A.
    Frank, G.
    Tjulandin, S.
    ANNALS OF ONCOLOGY, 2018, 29
12345